Laborate Pharmaceuticals India Limited
 | |
| Public limited company | |
| ISIN | 🆔 |
| Industry | Pharmaceuticals |
| Founded 📆 | |
| Founder 👔 | |
| Headquarters 🏙️ | Panipat, Haryana, India |
Area served 🗺️ | |
Key people | Ajay Bhatia, Sanjay Bhatia |
| Products 📟 | Pharmaceuticals, Generic Drugs, Ayurvedic, OTC, Personal Care |
| Members | |
Number of employees | 5000+ |
| Subsidiaries | Labolia Cosmetics |
| 🌐 Website | https://laborate.com/ |
| 📇 Address | |
| 📞 telephone | |
Laborate Pharmaceuticals India Limited is an Indian pharmaceutical company headquartered at Panipat, Haryana, India. The company manufactures and markets a wide range of medicines in India with a prime focus on pharmaceutical generics. It develops medicines in therapeutic areas including antibiotics, ophthalmic, gastrointestinal and antipyretics etc. It also manufactures nutraceuticals, OTC products, skin care products and herbal products. Laborate is a public limited company.
The company was formed in 1985.[1]. It has three manufacturing sites in India located in Panipat and Himachal Pradesh all of which have WHO-GMP certification[2]. It started working as a fully integrated pharmaceutical company in 1995 and began exports to foreign countries in the following year. In 2017, Sanjay Bhatia, Managing Director of Laborate received a rating of 99/100 from Owler’s tool, for being the most congenial CEO's in pharma.[3]
Controversy[edit]
In October 25, 2017, Madras High Court dismissed a plea filed by Laborate and other pharmaceutical firms for revoking the ban imposed on Diclofenac drug due to its impact on vultures, a critically endangered species considered to be declining in population mostly due to consumption of carcasses of livestock and cattle injected with Diclofenac, a painkiller[4]
On September 19, 2018, Laborate and other major pharmaceuticals firms challenged the Centre’s decision to ban fixed combination dose drugs(FDC’s). The Delhi High Court provided protection from coercive action against them for the stock already in the market, provided they stop manufacturing the prohibited medicines.[5]
References[edit]
- ↑ "Laborate Pharmaceuticals". 2019-01-26. Archived from the original on 2019-01-22. Retrieved 2020-09-22. Unknown parameter
|url-status=ignored (help) - ↑ "WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in various states of India" (PDF). cdsco.gov.in (PDF). 2018. pp. 65–66. Retrieved 2020-10-01. Unknown parameter
|url-status=ignored (help) - ↑ "Which pharma execs win the popularity contest? Roche grabs two top-3 slots, for one". FiercePharma. Retrieved 2020-09-22.
- ↑ S, Mohamed Imranullah (2017-10-25). "HC turns down plea of pharma firms in Diclofenac case". The Hindu. ISSN 0971-751X. Retrieved 2020-09-22.
- ↑ Reporter, Staff (2018-09-19). "High Court relief for pharmaceutical firms". The Hindu. ISSN 0971-751X. Retrieved 2020-09-22.
This article "Laborate Pharmaceuticals India Limited" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Laborate Pharmaceuticals India Limited. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
